Virion Therapeutics Company

Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally-associated cancers.
Industry: Viral Vectors
Headquarters: Newark, Delaware, United States
Founded Date: 2018-01-01
Funding Status: Early Stage Venture
Investors Number: 7
Total Funding: 14075858
Estimated Revenue: Less than $1M
Last Funding Date: 2020-08-24
Last Funding Type: Debt Financing

Visit Website
info@viriontx.com
Register and Claim Ownership